Literature DB >> 18799513

Pain assessment tools in palliative care: an urgent need for consensus.

M J Hjermstad1, J Gibbins, D F Haugen, A Caraceni, J H Loge, S Kaasa.   

Abstract

At present, there is no universally accepted cancer pain assessment tool for use in palliative care (PC). The European Palliative Care Research Collaborative (EPCRC), therefore, aims to develop an international consensus-based computerised pain assessment tool. As part of this process, we have performed (1) a literature review on pain assessment tools for use in the PC and (2) an international expert survey to gain information on the relevant dimensions for pain assessment in PC. 230 publications were identified, only six met the inclusion criteria. Three further articles were identified through manual searching, totalling 11 different pain assessment tools. Nine tools were multidimensional. Pain intensity was assessed in seven, using various numerical/verbal rating scales (NRS/VRS); five tools focused on pain management. Three publications did not identify the rationale for the need to develop a new tool, and the selection procedure for items/dimensions was not described in six tools. Patient and/or professional expert groups were involved in the development of five tools and only two tools were extensively validated or cross-culturally tested. Thirty-two experts (71%) completed the expert survey and identified 'intensity', 'temporal pattern', 'relief/exacerbation', 'pain quality' and 'location' as the five most relevant dimensions. Most preferred assessment of 'pain intensity' was by NRS rather than VRS. Time windows extending 24 h were regarded as less relevant. Development of PC pain assessment tools seems to be a continuous process, which does not adhere to systematic guidelines, thus does not contribute to a universally accepted tool. No tool contained all relevant dimensions as defined by the experts. Many tools focused on particular dimensions, suggesting that specific research interests may drive the tool development process. Extensive literature reviews, expert and patient input and clinical studies are a needed approach in the development of a new consensus-based pain assessment tool.

Entities:  

Mesh:

Year:  2008        PMID: 18799513     DOI: 10.1177/0269216308095701

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  21 in total

1.  Cancer pain--progress and ongoing issues in Europe.

Authors:  Stein Kaasa; Sebastiano Mercadante; Augusto Caraceni
Journal:  Pain Res Manag       Date:  2009 Sep-Oct       Impact factor: 3.037

2.  "We all talk about it as though we're thinking about the same thing." Healthcare professionals' goals in the management of pain due to advanced cancer: a qualitative study.

Authors:  Rebecca Bhatia; Bhatia Rebecca; Jane Gibbins; Gibbins Jane; Karen Forbes; Forbes Karen; Colette Reid; Reid Colette
Journal:  Support Care Cancer       Date:  2014-03-15       Impact factor: 3.603

3.  Reliability and concurrent validity of the Palliative Outcome Scale, the Rotterdam Symptom Checklist, and the Brief Pain Inventory.

Authors:  Marta Pelayo-Alvarez; Santiago Perez-Hoyos; Yolanda Agra-Varela
Journal:  J Palliat Med       Date:  2013-06-28       Impact factor: 2.947

4.  Comparative responsiveness of pain measures in cancer patients.

Authors:  Kurt Kroenke; Dale Theobald; Jingwei Wu; Wanzhu Tu; Erin E Krebs
Journal:  J Pain       Date:  2012-07-15       Impact factor: 5.820

5.  What Determines Whether a Pain is Rated as Mild, Moderate, or Severe? The Importance of Pain Beliefs and Pain Interference.

Authors:  Mark P Jensen; Catarina Tomé-Pires; Rocío de la Vega; Santiago Galán; Ester Solé; Jordi Miró
Journal:  Clin J Pain       Date:  2017-05       Impact factor: 3.442

Review 6.  Measurement of Chronic Pain and Opioid Use Evaluation in Community-Based Persons with Serious Illnesses.

Authors:  Kathleen Puntillo; Ramana K Naidu
Journal:  J Palliat Med       Date:  2017-11-01       Impact factor: 2.947

7.  Comparison of numerical and verbal rating scales to measure pain exacerbations in patients with chronic cancer pain.

Authors:  Cinzia Brunelli; Ernesto Zecca; Cinzia Martini; Tiziana Campa; Elena Fagnoni; Michela Bagnasco; Luigi Lanata; Augusto Caraceni
Journal:  Health Qual Life Outcomes       Date:  2010-04-22       Impact factor: 3.186

8.  Analgesia and central side-effects: two separate dimensions of morphine response.

Authors:  Joanne M Droney; Sophy K Gretton; Hiroe Sato; Joy R Ross; Ruth Branford; Kenneth I Welsh; William Cookson; Julia Riley
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

9.  Self-rated measure of pain frequency, intensity, and burden: psychometric properties of a new instrument for the assessment of pain.

Authors:  Adriane M dela Cruz; Ira H Bernstein; Tracy L Greer; Robrina Walker; Chad D Rethorst; Bruce Grannemann; Thomas Carmody; Madhukar H Trivedi
Journal:  J Psychiatr Res       Date:  2014-08-27       Impact factor: 4.791

10.  Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review.

Authors:  S Deandrea; O Corli; I Moschetti; G Apolone
Journal:  Ther Clin Risk Manag       Date:  2009-09-15       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.